Lactobacillus reuteri DSM 17938 and Improved Insulin Sensitivity

Doses used in studies

CFU/day: 100 million–10 billion (median 5.0 billion, IQR 100 million–10 billion) — 1 study

Time to effect

Median: 2.8 months · IQR 2.8 months–2.8 months · Range 2.8 months–2.8 months — Reported in 1 of 1 study

1 of 1 paper

Metabolic effects of Lactobacillus reuteri DSM 17938 in people with type 2 diabetes: A randomized controlled trial.

2017-02-07
RCT · n = 46
Diabetes, obesity & metabolism 19(4)
- Reza Mobini
- Valentina Tremaroli
- Marcus Ståhlman
- Fredrik Karlsson
- Max Levin
- Maria Ljungberg
- Maja Sohlin
- Heléne Bertéus Forslund
- Rosie Perkins
- Fredrik Bäckhed
- Per-Anders Jansson

PubMed: 28009106
DOI: 10.1111/dom.12861

5 Insights on

Improved Insulin Sensitivity

High evidence
Highly Cited
Clinical

Participants who received the highest dose of L. reuteri exhibited increases in insulin sensitivity index (ISI) ... but these differences were not significant in the between-group analyses

Effect: Neutral
Effect size: Small
Significant: No
Dose: 10^8 CFU/d or 10^10 CFU/d